The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
AstraZeneca’s Tagrisso (osimertinib) has been approved in the European Union (EU) for the adjuvant treatment of adult patients with early-stage (IB, ...
read more
Bristol Myers Squibb announced that the U.S. FDA approved Zeposia® (ozanimod) 0.92 mg for the treatment of adults with moderately to severely active ...
read more
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, will open its expanded production facilities ...
read more
The U.S. FDA issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy sotrovimab for the treatment of mild-to-...
read more
Spruce Biosciences Inc. presented data from its Phase 2 clinical trial of tildacerfont in adults with classic congenital adrenal hyperplasia (CAH) at ...
read more
Moderna a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality ...
read more
HitGen announced that it has entered into a research collaboration agreement with Dorian Therapeutics, a private biotechnology company developing ...
read more
Pfizer announced that the first enrolled subjects have received their immunizations as part of a new study in adults ages 65 or older exploring the ...
read more
Xeris Pharmaceuticals, Inc., a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use ...
read more
Ajinomoto Bio-Pharma Services (Aji Bio-Pharma), a leading provider of biopharmaceutical contract development and manufacturing services, announced the...
read more
AstraZeneca’s COVID-19 vaccine, Vaxzevria, has been granted special approval for emergency use in Japan for active immunization of individuals aged 18...
read more
On May 20, 2021, the Food and Drug Administration approved nivolumab (Opdivo, Bristol-Myers Squibb Company) for patients with completely resected ...
read more
Pfizer Inc. and BioNTech announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY®, the companies’ COVID-...
read more
Pfizer Inc. and BioNTech announced that BioNTech Europe has entered an agreement with Turkey’s Ministry of Health to supply 60 million additional ...
read more
Amphastar announced the FDA approved the Company’s ANDA for Dextrose injection 50% in the 50 mL Luer-Jet Prefilled Syringe System.
read more